As of 2025-09-06, the Relative Valuation of Taro Pharmaceutical Industries Ltd (TARO) is 65.86 USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.97 USD, the upside of Taro Pharmaceutical Industries Ltd based on Relative Valuation is 53.3%.
The range of the Relative Valuation is 52.96 - 81.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 44.1x | 39.7x |
| Forward P/E multiples | 28.4x - 39.2x | 36.2x |
| Fair Price | 52.96 - 81.03 | 65.86 |
| Upside | 23.2% - 88.6% | 53.3% |
| Date | P/E |